Official website (https://www.biogen.com/)
OverviewAI-generated
Biogen is an active company and funder established in 1978. It is located in Cambridge, United States, and was incorporated in Delaware. The organization operates in the biological products industry, specifically excluding diagnostic substances. It is recognized in the S&P 500 collection.
Biogen trades on the Nasdaq exchange under the ticker symbol BIIB. Its Central Index Key is 0000875045, and its Standard Industrial Classification code is 2836. The company’s fiscal year ends on December 31. It has also been known by the alias Biogen Idec.
Synthesized by Vinony from 26 facts across 5 sources: Wikidata, Firecrawl, SEC EDGAR, ROR, Vinony collections. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Key facts
- Company.name
- Biogen Inc.
- Company.logo
- Biogen.svg
- Company.logo_size
- 250px
- Company.image
- Biogen.jpg
- Company.image_size
- 240px
- Company.image_caption
- Headquarters in Cambridge, Massachusetts
- Company.former_name
- Biogen Idec Inc. (2003–2015)
- Company.type
- Public
- Company.industry
- Biotechnology
- Company.revenue
- (2025)
- Company.operating_income
- US$1.86billion (2025)
- Company.net_income
- US$1.29billion (2025)
- Company.assets
- US$29.4billion (2025)
- Company.equity
- US$18.3billion (2025)
- Company.num_employees
- 7,500 (2025)
via Wikipedia infobox
Company
BIIB- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- Nasdaq
- State of incorporation
- DE
- Entity type
- operating
- Latest filing
- SCHEDULE 13D/A · 2026-05-14
- Jurisdiction
- US-DE
- Headquarters
- Weston, US
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1978
- Location
- Cambridge, United States
- Also known as
- Biogen Idec
- Status
- Active
GRID grid.417832.b · ISNI 0000 0004 0384 8146
Official website
Home | Biogen
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
biogen.com →Link to the official site · 25,457 chars · not written by Vinony
Wikidata facts
- Part of
- S&P 500
- Country
- United States
- Founded by
- Charles Weissmann
- Headquarters
- Cambridge
- Owned by
- Renaissance Technologies
- Industry
- pharmaceutical industry
- Revenue
- 10173400000
- Stock exchange
- Nasdaq
- Legal form
- Delaware corporation
- Official website
- www.biogen.com
- Image
- Biogen.jpg
Show 7 more facts
- inception
- 1978-00-00
- social media followers
- 10000
- Commons category
- Biogen
- net profit
- 3046900000
- operating income
- 2840700000
- short name
- Biogen
- location of formation
- Geneva
Sources (9)
via Wikidata · CC0
On the map
3 mapped locations